University of Bayreuth, Presse release No. 163/2022 - 7 October 2022
Public online congress on quality assurance in the use of artificial hip joints
On November 10, 2022, the University of Bayreuth will host a public online congress on comprehensive quality assurance in the use of artificial hip joints. The focus will be on the question of what significance patient self-reports can have for quality assurance in hip arthroplasty. Participation is free of charge for all interested parties, prior online registration is required. Questions regarding quality assurance in the use of artificial hip joints can be submitted in advance until November 4, 2022.
Date: November 10, 2022, 3:00 p.m. to 6:15 p.m.
Congress programme: https://www.onkologie.uni-bayreuth.de/pool/dokumente/Einladung-und-Programm-Abschlusskongress-QualiPRO.pdf
Chair: Prof. Dr. Martin Emmert, Professor of Health Economics, Quality Management and Preference Research in Oncology at the University of Bayreuth.
Online registration: https://lmy.de/cfNki After registration, a link for online participation will be sent. Access to MicrosoftTeams is required for participation.
Registered participants* will have until November 4, 2022 to submit questions about quality assurance in hip arthroplasty via email to firstname.lastname@example.org. The questions will then be answered in a bundle during the online event.
The online event marks the conclusion of the project "Patient Reported Outcomes for Quality Assurance in Endoprosthetics? - Results of the Innovation Fund Project QualiPRO." The research project, which started in 2019, was funded for 38 months with a total of 1.4 million euros from the Joint Federal Committee Innovation Fund. In addition to the University of Bayreuth, partner institutions in the project were the Hannover University of Applied Sciences and Arts, the Friedrich Alexander University Erlangen-Nuremberg, the Hannover Medical School, the DIAKOVERE Annastift in Hannover, the AOK Lower Saxony, the IGES Institut GmBH in Berlin, and the Clinische Studien Gesellschaft - CSG in Berlin.
Within the framework of QualiPRO, more than 720 patients in 10 hospitals were interviewed about their personal experiences with the insertion of an artificial hip joint. The congress will now address the question of how these "Patient Reported Outcomes (PRO)" can contribute to improving medical quality in the field of hip arthroplasty. Among other things, this will involve the relationship between subjective self-reported outcomes and objective clinical care data, and an evaluative comparison of PROs with other quality assurance methods.
"Already in 2016, more than 200,000 patients in Germany received an artificial hip joint. Since then, different initiatives and procedures for quality management in this central field of joint prosthetics have been developed in the health sciences. Our online congress is intended to serve the exchange of experiences and to highlight the special importance of self-reporting by those affected. The results will possibly also be transferable to other fields of surgical prosthetics," says congress director Prof. Dr. Martin Emmert.